Detection and Prevalence of Penicillin-Susceptible Staphylococcus aureus in the United States in 2013

Journal of Clinical Microbiology
S S RichterD J Diekema

Abstract

Using blaZ PCR as the "gold standard," the sensitivities of CLSI penicillin zone edge and nitrocefin-based tests for β-lactamase production in Staphylococcus aureus were 64.5% and 35.5%, respectively, with specificity of 99.8% for both methods. In 2013, 13.5% of 3,083 S. aureus isolates from 31 U.S. centers were penicillin susceptible.

References

Apr 11, 2001·Emerging Infectious Diseases·H F Chambers
Apr 10, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M KaaseS G Gatermann
Aug 9, 2013·The Journal of Antimicrobial Chemotherapy·John K Crane
Jan 24, 2014·Journal of Clinical Microbiology·Lito E PapanicolasIvan Bastian
Jan 31, 2014·Journal of Clinical Microbiology·Lynette A PereiraDavid J Speers
Sep 13, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y P ChongY S Kim
Sep 6, 2015·The Journal of Antimicrobial Chemotherapy·Matthew R ChabotJulius Larioza

❮ Previous
Next ❯

Citations

Aug 1, 2018·Antimicrobial Agents and Chemotherapy·Karen Bush
Jan 16, 2019·JAMA : the Journal of the American Medical Association·Erica S ShenoyKimberly G Blumenthal
Feb 28, 2020·Clinical Microbiology Reviews·Karen Bush, Patricia A Bradford
May 15, 2020·Clinical Microbiology Reviews·David M P De OliveiraMark J Walker
Feb 23, 2021·The Journal of Antimicrobial Chemotherapy·Robert SkovBrandi M Limbago
Mar 14, 2021·Applied and Environmental Microbiology·Mathias GalliqueNathalie Tufenkji
May 11, 2021·ACS Nano·Mohamed A Abdou MohamedWarren C W Chan
Jul 11, 2021·The Journal of Antimicrobial Chemotherapy·Olouwafemi Mistourath MamaUNKNOWN Spanish Study Group of Clinical S. aureus CC398
Sep 17, 2021·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Helle Brander EriksenBarbara Juliane Holzknecht

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.